4basebio PLC announced a further expansion of its UK facilities. In light of the continued expansion of its commercial capabilities, 4BB is relocating its manufacturing and quality assurance teams to new premises adjacent to its existing clean room facilities. Consequently, it has entered into a lease to rent the premises which provide dedicated laboratory, warehousing and office space for those teams. The additional property brings the overall footprint in the UK to 21,000 square feet and reflects the growth in the UK team to more than 60 staff and provides room for further expansion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,070 GBX | -4.46% | +3.38% | +57.35% |
Apr. 10 | 4basebio to supply synthetic DNA for mRNA vaccine program | AN |
Apr. 10 | 4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+57.35% | 171M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 4BB Stock
- News 4basebio PLC
- 4basebio PLC Announces Further Expansion of Its UK Facilities